Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
3(21%)
Results Posted
50%(4 trials)

Phase Distribution

Ph not_applicable
2
14%
Ph phase_1
1
7%
Ph phase_3
6
43%
Ph phase_4
4
29%

Phase Distribution

1

Early Stage

0

Mid Stage

10

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 3Large-scale testing
6(46.2%)
Phase 4Post-market surveillance
4(30.8%)
N/ANon-phased studies
2(15.4%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

3

trials recruiting

Total Trials

14

all time

Status Distribution
Active(3)
Completed(8)
Terminated(1)
Other(2)

Detailed Status

Completed8
Recruiting3
unknown2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 36 (46.2%)
Phase 44 (30.8%)
N/A2 (15.4%)

Trials by Status

recruiting321%
withdrawn17%
unknown214%
completed857%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials

All 14 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
14